Skip to Main Content

Browse issues

Clinical Infectious Diseases Cover Image for Volume 66, Issue 12
Volume 66, Issue 12
15 June 2018
ISSN 1058-4838
EISSN 1537-6591

Volume 66, Issue 12, 15 June 2018

NEWS

Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages i–ii, https://doi.org/10.1093/cid/ciy308

IN THE LITERATURE

Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages iii–iv, https://doi.org/10.1093/cid/ciy361

ARTICLES AND COMMENTARIES

Ghyslain Mombo-Ngoma and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1823–1830, https://doi.org/10.1093/cid/cix1122

Fosmidomycin–piperaquine is being developed as nonartemisinin-based combination therapy to meet the challenge of emerging artemisinin resistance. The combination appeared to have high efficacy and be safe and well tolerated despite observed transient changes in electrocardiogram with prolongation of the QT interval.

Hideo Okuno and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1831–1837, https://doi.org/10.1093/cid/cix1126

We analyzed national surveillance data on influenza-associated encephalopathy (IAE) cases reported in Japan from 2010 through 2015. We found differences in the clinical features of IAE between adults and children. Fatal outcomes were higher in patients aged ≥40 years.

Benedikt Hogan and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1838–1845, https://doi.org/10.1093/cid/cix1120

In malaria patients admitted to the study hospital, the likelihood of a co-diagnosis decreased with an increasing parasite count. In malaria-endemic settings, parasite densities provide important information for patient management, in particular for antimicrobial medication.

Alexander J Stockdale and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1846–1857, https://doi.org/10.1093/cid/cix1108

In sub-Saharan Africa, second-line ritonavir-boosted protease inhibitor–based antiretroviral therapy led to virological suppression in 69.3% of participants at week 48 and 61.5% at week 96, based on an intention-to-treat meta-analysis of 4558 participants (14 studies) and 2145 participants (8 studies), respectively.

Gerardo J Sánchez and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1858–1863, https://doi.org/10.1093/cid/cix1103

This was the first birth cohort study with active surveillance of sapovirus infection in a developing country. High incidences of sapovirus infection and associated diarrhea during the first 2 years of life were reported. Sapovirus reinfection is common but rare with the same genotype.

Luke C Kingry and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1864–1871, https://doi.org/10.1093/cid/cix1107

Broad molecular surveillance for Borrelia species in patients suspected of tickborne illness followed by next-generation sequence typing provides insight into the different Borrelia species causing human illness and geographical distribution of Borrelia infections and sequence types throughout the United States.

Jennifer A Manuzak and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1872–1882, https://doi.org/10.1093/cid/cix1116

We assessed whether cannabis use was associated with altered immune activation in antiretroviral-treated, HIV-infected individuals. Heavy cannabis use was associated with decreased frequencies of activated T cells and inflammatory monocytes, providing evidence of a potential immunological benefit of cannabinoids.

Fitsum G Tadesse and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1883–1891, https://doi.org/10.1093/cid/cix1123

Microscopically detectable asymptomatic Plasmodium vivax and Plasmodium falciparum infections form the most important source of onward mosquito infections in a low-endemic setting in Ethiopia. Plasmodium vivax symptomatic infections are highly infectious but less prevalent and thereby contribute less to transmission.

Aamer Imdad and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1892–1898, https://doi.org/10.1093/cid/cix1128

Culture-independent diagnostic test (CIDTs) are increasingly used to diagnose enteric infections; however, public health surveillance of foodborne illnesses has historically depended on isolates. This study found that CIDT-positive specimens yielded a pathogen in only 61% of reported cases compared to culture-derived isolates.

James H Cole and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1899–1909, https://doi.org/10.1093/cid/cix1124

Longitudinal neuroimaging and neuropsychological assessments were used to study aging-related brain changes in people living with HIV on successful antiretroviral therapy. No differences in brain structure or cognitive function were seen over 2 years, compared to closely matched HIV-negative controls.

Stéphane Hua and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1910–1917, https://doi.org/10.1093/cid/cix1111

In antiretroviral-treated HIV-1/hepatitis C virus–coinfected patients, IFN-α treatment decreases cell-associated HIV-1 DNA levels, changes the natural killer (NK) cell subset distribution, and activates NK cells. Frequency and activation of NK cells are associated with lower cell-associated HIV-1 DNA.

Thanh Tran and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1918–1927, https://doi.org/10.1093/cid/cix1121

Concurrent characterization of skeletal muscle, physical function, and immune profile in middle-aged HIV-infected adults revealed atypical skeletal muscle with increased internalized myonuclei and decreased PGC-1α, in the context of fatigue, physical function deficits, and persistent inflammation and immune activation.

John E Edwards and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1928–1936, https://doi.org/10.1093/cid/ciy185

This first-in-humans, exploratory phase 1b/2a study of an active Candida vaccine containing the N-terminus of the Als3 adhesin/invasin found it was safe, well-tolerated, and immunogenic and significantly reduced episodes of symptoms in patients aged <40 years with recurrent vulvovaginal candidiasis.

Arturo Casadevall and Liise-anne Pirofski
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1937–1939, https://doi.org/10.1093/cid/ciy188
John P Donnelly and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1940–1947, https://doi.org/10.1093/cid/cix1109

Individuals residing in areas of high neighborhood socioeconomic status (nSES) demonstrated lower rates of infection and sepsis relative to those in low-nSES neighborhoods. Individual income and physical function mediate the association, highlighting pathways through which nSES could impact infection risk.

Tingting Huo and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1948–1952, https://doi.org/10.1093/cid/cix1118

In this cross-sectional study, concomitant chronic hepatitis B virus (HBV) infection significantly increases the risk of colorectal liver metastasis; for hepatitis B surface antigen–positive colorectal cancer patients, elevated FIB-4/APRI may be antimetastatic; whether active HBV replication is prometastatic needs further study.

BRIEF REPORTS

Sarah E Kleinstein and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1953–1956, https://doi.org/10.1093/cid/cix1051
Troy Watson and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1957–1959, https://doi.org/10.1093/cid/cix1112

REVIEW ARTICLE

Anna Lena Lopez and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1960–1971, https://doi.org/10.1093/cid/cix1039

Current immunologic and clinical data suggest that protection conferred by a single dose of killed oral cholera vaccine may be sufficient to reduce short-term risk in outbreaks or other high-risk settings, which may be especially useful when vaccine supply is limited.

PHOTO QUIZ

Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Page 1972, https://doi.org/10.1093/cid/cix1044

ANSWER TO THE PHOTO QUIZ

Hideyuki Kosumi and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1973–1974, https://doi.org/10.1093/cid/cix1049

CORRESPONDENCE

Masayuki Nigo and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1975–1976, https://doi.org/10.1093/cid/ciy041
Gauri S Godbole and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1976–1977, https://doi.org/10.1093/cid/ciy032
Stefan Schlabe and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1977–1978, https://doi.org/10.1093/cid/ciy033
Kentaro Tochitani and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Page 1978, https://doi.org/10.1093/cid/ciy042
Majdi N Al-Hasan and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1978–1979, https://doi.org/10.1093/cid/ciy043
Darunee Chotiprasitakul and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1979–1981, https://doi.org/10.1093/cid/ciy046
Aurélien Dinh and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1981–1982, https://doi.org/10.1093/cid/ciy047
Sarah H Yi and others
Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Pages 1982–1983, https://doi.org/10.1093/cid/ciy049

COVER

Clinical Infectious Diseases, Volume 66, Issue 12, 15 June 2018, Page NP, https://doi.org/10.1093/cid/ciy369
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close